Literature DB >> 20083003

What do clinical trials tell us about treating patients?

William J Weiner1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20083003     DOI： 10.1016/S1353-8020(09)70776-X

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  6 in total

Review 1.  Clinical Pharmacokinetics and Pharmacodynamics of Safinamide.

Authors:  Thomas Müller; Paul Foley
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447

2.  Drug therapy in patients with Parkinson's disease.

Authors:  Thomas Müller
Journal:  Transl Neurodegener       Date:  2012-05-24       Impact factor: 8.014

Review 3.  Emerging approaches in Parkinson's disease - adjunctive role of safinamide.

Authors:  Thomas Müller
Journal:  Ther Clin Risk Manag       Date:  2016-08-02       Impact factor: 2.423

Review 4.  Safinamide: an add-on treatment for managing Parkinson's disease.

Authors:  Thomas Müller
Journal:  Clin Pharmacol       Date:  2018-04-05

Review 5.  View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson's Disease: Are We on the Right Track?

Authors:  Thomas Müller
Journal:  Biologics       Date:  2021-07-29

Review 6.  Clinical and economic burden of adverse drug reactions.

Authors:  Janet Sultana; Paola Cutroneo; Gianluca Trifirò
Journal:  J Pharmacol Pharmacother       Date:  2013-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.